Luca Moscetti
Azienda Ospedaliero-Universitaria di Modena(IT)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial(2013)477 cited
- → Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study(2021)370 cited
- → Natural History of Non-Small-Cell Lung Cancer with Bone Metastases(2015)137 cited
- → Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center(2011)118 cited
- → Triple positive breast cancer: A distinct subtype?(2014)117 cited
- → Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)(2005)98 cited
- → Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era(2021)95 cited
- → Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial(2018)87 cited
- → Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges(2023)86 cited
- → Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going(2018)75 cited